The UVA Cancer Center seeks adults ages 18 and over with urothelial (bladder) cancer for a clinical trial. The purpose of this study is to evaluate a chemotherapy drug (enfortumab vedotin) alone or in combination with other anticancer therapies in patients with urothelial cancer. Disease response and good and bad effects of the drug will be studied as part of this study. Study specific tests will be provided at no cost to you.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT03288545
Up to $200 for hotel stay and up to $100 for travel costs.